Suppr超能文献

苯并[d]咪唑衍生物的合成、血管舒张活性和降压作用。

Synthesis, vasorelaxant activity and antihypertensive effect of benzo[d]imidazole derivatives.

机构信息

Universidad Autónoma del Estado de Morelos, Cuernavaca, Mor. 62209, Mexico.

出版信息

Bioorg Med Chem. 2010 Jun 1;18(11):3985-91. doi: 10.1016/j.bmc.2010.04.027. Epub 2010 Apr 14.

Abstract

A series of 1H-benzo[d]imidazole analogues of Pimobendan, substituted at position 5 with either -CF(3) or -NO(2), were synthesized using a short synthetic route. All the nitro derivatives were potent, and exhibited a concentration- and partial endothelium-dependent vasorelaxant effects, with EC(50)s <5microM. 2-Methoxy-4-[5-nitro-1H-benzo[d]imidazol-2-yl]phenol (compound 13) was the most potent derivative of the series, showing an EC(50) value of 1.81microM and E(max) of 91.7% for ex vivo relaxant response in intact aortic rings, resulting in a 2.5-fold higher activity compared to Pimobendan. The closely related 5-CF(3) analogue (compound 8), was 19 times less potent than 13. The antihypertensive activity of compound 13 was evaluated at doses of 25, 50 and 100mgkg(-1), using spontaneously hypertensive rats (SHR), showing a statistically significant dose-dependent effect.

摘要

采用短的合成路线,合成了一系列取代基为- CF(3)或- NO(2)的位于 5 位的匹莫苯丹 1H-苯并二咪唑类似物。所有的硝基衍生物都具有很强的效力,表现出浓度依赖性和部分内皮依赖性血管舒张作用,EC(50)值<5μM。2-甲氧基-4-[5-硝基-1H-苯并二咪唑-2-基]苯酚(化合物 13)是该系列中最有效的衍生物,在完整的主动脉环中,其体外舒张反应的 EC(50)值为 1.81μM,E(max)为 91.7%,与匹莫苯丹相比,活性提高了 2.5 倍。与 13 密切相关的 5-CF(3)类似物(化合物 8)的效力比 13 低 19 倍。在自发性高血压大鼠(SHR)中,以 25、50 和 100mgkg(-1)的剂量评价了化合物 13 的抗高血压活性,显示出具有统计学意义的剂量依赖性作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验